Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 45, 2021 - Issue 4
209
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Hb Calgary (HBB: c.194G>T): A Highly Unstable Hemoglobin Variant with a β-Thalassemia Major Phenotype

ORCID Icon, , , , , , , , , & show all
Pages 215-219 | Received 03 Jun 2021, Accepted 29 Jun 2021, Published online: 26 Jul 2021
 

Abstract

We describe two unrelated patients, both heterozygous for an unstable hemoglobin (Hb) variant named Hb Calgary (HBB: c.194G>T) that causes severe hemolytic anemia and dyserythorpoietic, resulting in transfusion dependence and iron overload. The molecular pathogenesis is a missense variation on the β-globin gene, presumed to lead to an unstable Hb. The phenotype of Hb Calgary is particularly severe presenting as transfusion-dependent anemia in early infancy, precluding phenotypic diagnosis and highlighting the importance of early genetic testing in order to make an accurate diagnosis.

Acknowledgements

The authors acknowledge Dr. Bjørn Dalhus, Department of Medical Biochemistry, Institute of Clinical Medicine, University of Oslo, Oslo, Norway, for his input on the substitution’s effect on protein structure.

Disclosure statement

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.